Shares of Unichem Laboratories added 3.5 percent intraday Wednesday after company received tentative approval from USFDA.
The company has received tentative approval for its ANDA, Tadalafil tablets, 2.5 mg, 5 mg, 10 mg and 20 mg from the United States Food and Drug Administration (USFDA) for a generic version of ELI LILLY’s Cialis, 2.5 mg, 5 mg, 10 mg and 20 mg.
Tadalafil tablets indicated for the treatment of erectile dysfunction, treatment of the sign and symptoms of benign prostatic hyperplasia and treatment of ED and the signs and symptoms of BPH.
Currently, it is trading 49.16 percent below its 52-week high and 6.7 percent above its 52-week low.
At 12:07 hrs Unichem Laboratories was quoting at Rs 194.20, up Rs 2.95, or 1.54 percent on the BSE.
